Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00947154
What this trial is testing

Trial of Aripiprazole in Trichotillomania

Who this might be right for
Trichotillomania
Stanford University 12
Large-scale testing (Phase 3)Study completedNCT00237913
What this trial is testing

Schizophrenia Trial of Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 700
Post-approval studies (Phase 4)Study completedNCT01052389
What this trial is testing

Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Mario Negri Institute for Pharmacological Research 300
Large-scale testing (Phase 3)Study completedNCT00706589
What this trial is testing

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

Who this might be right for
Chronic Motor or Vocal Tic DisorderTourette's Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 61
Not applicableUnknownNCT02334904
What this trial is testing

Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI

Who this might be right for
First-Episode PsychosisBipolar Disorder
University of British Columbia 60
Post-approval studies (Phase 4)Study completedNCT02146547
What this trial is testing

European Long-acting Antipsychotics in Schizophrenia Trial

Who this might be right for
Schizophrenia
UMC Utrecht 536
Large-scale testing (Phase 3)Not Yet RecruitingNCT06589817
What this trial is testing

A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

Who this might be right for
Acute Schizophrenia
Chengdu Kanghong Pharmaceutical Group Co., Ltd. 376
Not applicableStudy completedNCT00374348
What this trial is testing

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Who this might be right for
Schizophrenia OCDObsessive Compulsive Disorder
Jamaica Hospital Medical Center 10
Post-approval studies (Phase 4)Study completedNCT00194038
What this trial is testing

Aripiprazole in Late Life Bipolar Disorder

Who this might be right for
Bipolar Disorder
University Hospitals Cleveland Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05545891
What this trial is testing

Aripiprazole in Body Focused Repetitive Behaviors

Who this might be right for
Trichotillomania (Hair-Pulling Disorder)Dermatillomania
University of Chicago 100
Post-approval studies (Phase 4)Study completedNCT00088049
What this trial is testing

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 560
Not applicableStudy completedNCT03130478
What this trial is testing

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 119
Large-scale testing (Phase 3)Study completedNCT00094432
What this trial is testing

Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 650
Not applicableUnknownNCT03130465
What this trial is testing

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 636
Post-approval studies (Phase 4)Ended earlyNCT02472652
What this trial is testing

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Who this might be right for
Sexual Dysfunction
Gazda, Thomas D., M.D., PC 2
Post-approval studies (Phase 4)UnknownNCT02532491
What this trial is testing

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 200
Large-scale testing (Phase 3)Study completedNCT00440713
What this trial is testing

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms

Who this might be right for
Posttraumatic Stress Disorder
Federal University of São Paulo 40
Large-scale testing (Phase 3)Study completedNCT00105196
What this trial is testing

Aripiprazole in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 349
Post-approval studies (Phase 4)Study completedNCT01188668
What this trial is testing

Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects

Who this might be right for
PharmacokineticsCytochrome P-450 CYP2D6CYP3A4 Protein, Human
Pfizer 38
Early research (Phase 1)Study completedNCT02636842
What this trial is testing

Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Alkermes, Inc. 47
Next Page